Additional file 1: Table 1. Comparison of global amyloid-PET and global tau-PET as predictors of future cognitive decline, stratified by amyloid-status. Table 2. Regression model of tau-PET corrected for amyloid-PET as a predictor of future cognitive decline, stratified by amyloid-status. Table 3. Effect sizes between Braak-stage groups and cognitive decline. Table 4. Distribution of Braak-stage groups, stratified by amyloid-status. Table 5. Association between Braak-stage and cognitive decline in amyloid positives. Figure 1. Tau-PET-based Braak-staging versus annual cognitive change rates in amyloid positives
[Background] We investigated regional amyloid staging characteristics in 11C-PiB-PET data from middl...
Table S2. Associations between in vivo amyloid stage and cognitive performance. Analysis of Covarian...
A major unanswered question in the dementia field is whether cognitively unimpaired individuals who ...
BACKGROUND To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic...
BACKGROUND To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic...
BACKGROUND To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic...
BACKGROUND To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic...
Introduction: Biomarkers for the prediction of cognitive decline in patients with amnestic mild cogn...
Introduction: Biomarkers for the prediction of cognitive decline in patients with amnestic mild cogn...
Amyloid-beta (Aβ) and tau pathologies are commonly observed among clinically normal older individual...
OBJECTIVES: Amyloid-beta (Aβ) and tau pathologies are commonly observed among clinically normal olde...
A biological research framework to define Alzheimer' disease with dichotomized biomarker measurement...
Figure S4. Amyloid progression model in the INSIGHT-preAD data. This figure shows the amyloid progre...
A biological research framework to define Alzheimer’ disease with dichotomized biomarker measurement...
A biological research framework to define Alzheimer’ disease with dichotomized biomarker measurement...
[Background] We investigated regional amyloid staging characteristics in 11C-PiB-PET data from middl...
Table S2. Associations between in vivo amyloid stage and cognitive performance. Analysis of Covarian...
A major unanswered question in the dementia field is whether cognitively unimpaired individuals who ...
BACKGROUND To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic...
BACKGROUND To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic...
BACKGROUND To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic...
BACKGROUND To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic...
Introduction: Biomarkers for the prediction of cognitive decline in patients with amnestic mild cogn...
Introduction: Biomarkers for the prediction of cognitive decline in patients with amnestic mild cogn...
Amyloid-beta (Aβ) and tau pathologies are commonly observed among clinically normal older individual...
OBJECTIVES: Amyloid-beta (Aβ) and tau pathologies are commonly observed among clinically normal olde...
A biological research framework to define Alzheimer' disease with dichotomized biomarker measurement...
Figure S4. Amyloid progression model in the INSIGHT-preAD data. This figure shows the amyloid progre...
A biological research framework to define Alzheimer’ disease with dichotomized biomarker measurement...
A biological research framework to define Alzheimer’ disease with dichotomized biomarker measurement...
[Background] We investigated regional amyloid staging characteristics in 11C-PiB-PET data from middl...
Table S2. Associations between in vivo amyloid stage and cognitive performance. Analysis of Covarian...
A major unanswered question in the dementia field is whether cognitively unimpaired individuals who ...